Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$496 Hold
13
﹤0.01% 3724
2025
Q4
$284 Buy
+13
New +$270 ﹤0.01% 3262
2025
Q3
Sell
-36,349
Closed -$932K 2301
2025
Q2
$932K Buy
36,349
+12,578
+53% +$368K ﹤0.01% 2398
2025
Q1
$870K Sell
23,771
-300
-1% -$10.3K ﹤0.01% 2367
2024
Q4
$738K Buy
24,071
+1,529
+7% +$50.8K ﹤0.01% 2461
2024
Q3
$849K Sell
22,542
-1,931
-8% -$74.4K ﹤0.01% 2467
2024
Q2
$969K Buy
24,473
+10,781
+79% +$349K ﹤0.01% 2382
2024
Q1
$460K Hold
13,692
﹤0.01% 2312
2023
Q4
$456K Hold
13,692
﹤0.01% 2348
2023
Q3
$430K Hold
13,692
﹤0.01% 2350
2023
Q2
$452K Hold
13,692
﹤0.01% 2364
2023
Q1
$452K Buy
13,692
+1,749
+15% +$57.3K ﹤0.01% 2364
2022
Q4
$384K Hold
11,943
﹤0.01% 2276
2022
Q3
$427K Buy
11,943
+1,754
+17% +$72.8K ﹤0.01% 2396
2022
Q2
$418K Buy
10,189
+2,074
+26% +$101K ﹤0.01% 2365
2022
Q1
$470K Hold
8,115
﹤0.01% 2483
2021
Q4
$477K Sell
8,115
-540
-6% -$32.8K ﹤0.01% 2577
2021
Q3
$525K Buy
8,655
+4,578
+112% +$268K ﹤0.01% 2481
2021
Q2
$245K Buy
+4,077
New +$204K ﹤0.01% 2685
2016
Q3
Sell
-55,096
Closed -$1.18M 2596
2016
Q2
$1.18M Sell
55,096
-149,258
-73% -$4.7M ﹤0.01% 1573
2016
Q1
$7.02M Buy
204,354
+176,608
+637% +$4.67M 0.01% 940
2015
Q4
$763K Sell
27,746
-4,734
-15% -$129K ﹤0.01% 1846
2015
Q3
$971K Buy
32,480
+57
+0.2% +$1.87K ﹤0.01% 1735
2015
Q2
$1.37M Buy
32,423
+1,123
+4% +$53K ﹤0.01% 1566
2015
Q1
$1.56M Buy
+31,300
New +$1.52M ﹤0.01% 1468

Other funds holding ATEX

UBS AM's ATEX Position: Q1 2026 in Review

UBS AM held its Anterix (ATEX) position steady in Q1 2026 at 13 shares worth $496. The position accounts for ﹤0.01% of the portfolio, ranked #3724.

UBS AM first reported a position in ATEX in Q1 2015 and has held it in 25 quarters since. The position peaked at $7.02M in Q1 2016. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • UBS AM held 13 shares of Anterix worth $496 as of Q1 2026.
  • UBS AM left its Anterix share count unchanged in Q1 2026.
  • Anterix made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #3724 holding.
  • UBS AM first reported a position in Anterix in Q1 2015 and has held it in 25 quarters since.
  • UBS AM's Anterix position peaked at $7.02M in Q1 2016.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.